GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Notes Receivable

Accustem Sciences (Accustem Sciences) Notes Receivable : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Notes Receivable?

Accustem Sciences's Notes Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.


Accustem Sciences Notes Receivable Historical Data

The historical data trend for Accustem Sciences's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Notes Receivable Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
Notes Receivable
- -

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Accustem Sciences Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Accustem Sciences Notes Receivable Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Accustem Sciences (Accustem Sciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.